IQVIA HOLDINGS INC (IQV) Stock Price, Forecast & Analysis
NYSE:IQV • US46266C1053
IQV Key Statistics, Chart & Performance
The current stock price of IQV is 161.91 USD. In the past month the price decreased by -32.83%. In the past year, price decreased by -14.24%.
IQV Technical Analysis
IQV Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to IQV. While IQV has a great profitability rating, there are quite some concerns on its financial health.
IQV Financial Highlights
Over the last trailing twelve months IQV reported a non-GAAP Earnings per Share(EPS) of 11.93. The EPS increased by 7.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.34% | ||
| ROA | 4.54% | ||
| ROE | 20.91% | ||
| Debt/Equity | 2.14 |
IQV Forecast & Estimates
30 analysts have analysed IQV and the average price target is 265.69 USD. This implies a price increase of 64.1% is expected in the next year compared to the current price of 161.91.
For the next year, analysts expect an EPS growth of 9.67% and a revenue growth 6.51% for IQV
IQV Ownership
IQV Latest News, Press Relases and Analysis
IQV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.69 | 193.716B | ||
| DHR | DANAHER CORP | 24.67 | 147.876B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 143.62 | 47.316B | ||
| A | AGILENT TECHNOLOGIES INC | 20.6 | 35.185B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.85 | 28.049B | ||
| WAT | WATERS CORP | 22.08 | 19.425B | ||
| ILMN | ILLUMINA INC | 23.54 | 18.779B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.58 | 17.653B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.06 | 12.457B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IQV
Company Profile
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Company Info
IQVIA HOLDINGS INC
2400 Ellis Road
Durham NORTH CAROLINA 27703 US
CEO: Ari Bousbib
Employees: 91000
Phone: 19199982000
IQVIA HOLDINGS INC / IQV FAQ
Can you describe the business of IQVIA HOLDINGS INC?
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Can you provide the latest stock price for IQVIA HOLDINGS INC?
The current stock price of IQV is 161.91 USD. The price decreased by -1.8% in the last trading session.
What is the dividend status of IQVIA HOLDINGS INC?
IQV does not pay a dividend.
What is the ChartMill rating of IQVIA HOLDINGS INC stock?
IQV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for IQV stock?
30 analysts have analysed IQV and the average price target is 265.69 USD. This implies a price increase of 64.1% is expected in the next year compared to the current price of 161.91.
What is the GICS sector and industry of IQV stock?
IQVIA HOLDINGS INC (IQV) operates in the Health Care sector and the Life Sciences Tools & Services industry.
What is IQVIA HOLDINGS INC worth?
IQVIA HOLDINGS INC (IQV) has a market capitalization of 27.46B USD. This makes IQV a Large Cap stock.